文章摘要

贝伐单抗联合吉非替尼一线治疗晚期 EGFR 突变的肺腺癌的临床观察

作者: 1董磊
1 海港医院肿瘤科,河北 秦皇岛 066000
通讯:

Clinical observation of bevacizumab combined with gefitinib in first-line treatment of advanced lung adenocarcinoma with EGFR mutation

Authors: 1DONG Lei
1 Oncology Department, Haigang Hospital, Qinhuangdao Hebei 066000, China

文章选项